Latest news
Loading news…
Thryv Therapeutics
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 MediumHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals. Laval, Quebec, Canada Founded 2019 11-50 employees For Profit
Thryv Therapeutics is a precision medicine approach to treat patients with Long QT Syndrome and potentially other arrhythmias.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
13
Patents
7
3 trademarks
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 20
- Patents granted
- 7
- Trademarks
- 3
- Top patent class
- Medical Or Veterinary Science; Hygiene
- IT spend
- $162K
Company Info
- Founded
- 2019
- Employees
- 11-50
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- Founders
- 2
- News articles
- 55
- HQ
- Laval, Quebec, Canada
Signals & Scores
- Heat score
- Medium
- Growth score
- Low
- Trend (7d)
- 0
- Trend (30d)
- -0.9
- Trend (90d)
- 2.8
- Last leadership hire
- Nov 19, 2025
Key People at Thryv Therapeutics
CMO
CEO, Co-Founder
13
professional contacts at Thryv Therapeutics
Contact execs at Thryv Therapeutics →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Thryv Therapeutics
Loading news…
FAQs about Thryv Therapeutics
People who checked this page also checked these
Browse the full Acquirezy directory.